You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

EFIDAC 24 CHLORPHENIRAMINE MALEATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Efidac 24 Chlorpheniramine Maleate, and what generic alternatives are available?

Efidac 24 Chlorpheniramine Maleate is a drug marketed by Alza and is included in one NDA.

The generic ingredient in EFIDAC 24 CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Efidac 24 Chlorpheniramine Maleate

A generic version of EFIDAC 24 CHLORPHENIRAMINE MALEATE was approved as chlorpheniramine maleate by AVANTHI INC on May 13th, 2009.

  Try a Trial

US Patents and Regulatory Information for EFIDAC 24 CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EFIDAC 24 CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 ⤷  Try a Trial ⤷  Try a Trial
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 ⤷  Try a Trial ⤷  Try a Trial
Alza EFIDAC 24 CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 019746-002 Nov 18, 1994 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for EFIDAC 24 CHLORPHENIRAMINE MALEATE

See the table below for patents covering EFIDAC 24 CHLORPHENIRAMINE MALEATE around the world.

Country Patent Number Title Estimated Expiration
Japan H0784385 ⤷  Try a Trial
Japan S59167513 OSMOTIC PRESSURE-UTILIZING DRUG-RELEASING SYSTEM ⤷  Try a Trial
Israel 71112 OSMOTIC SYSTEM WITH INSTANT DRUG AVAILABILITY ⤷  Try a Trial
Greece 3001277 ⤷  Try a Trial
Italy 1182253 DISPOSITIVO AD AZIONE OSMOTICA PER LA SOMMINISTRAZIONE DI UN AGENTE BENEFICO ALL AMBIENTE CIRCOSTANTE PARTICOLARMENTE PER LA SOMMINISTRAZIONE DI FARMACI IN AMBITO GASTROINTE STINALE ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.